Post Profile






Sanofi's dengue vaccine approved in 11 countries

PARIS (Reuters) - Sanofi Pasteur, Sanofi's vaccines unit, said on Tuesday that its dengue vaccine, Dengvaxia, had received market approval in eleven countries.
read more

share
See more about: Sanofi Pasteur

Related Posts


FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered By Intradermal Microinjection

Health : Medical News Today

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced the U.S. Food and Drug Administration (FDA) has approved the company's supplemental biologics license application (sBLA) for licensure of Fluzo...

FDA Approves Sanofi's 4-Strain Influenza Vaccine

Health : Medical News Today

The U.S. Food and Drug Administration has just announced the approval of the first and only 4-strain influenza vaccine for children as young as 6 months. Sanofi Pasteur, the vaccines division of the French drugmaker Sanofi, said its...

European Medicines Agency Recommends Approval Of Hexyon 6-In-1 Paediatric Vaccine

Health : Medical News Today

Upon approval Hexyon will be the only fully liquid, ready-to-use 6-in-1 paediatric vaccine in Europe Sanofi Pasteur MSD, the joint venture between MSD and Sanofi Pasteur in Europe, announced today that their innovative 6-in-1 paedia...

Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study

Health : Medical News Today

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT : SAN and NYSE : SNY), announced that its investigational tetravalent dengue vaccine is entering into a pediatric clinical study in Thailand to assess the effic...

Sanofi Pasteur's Dengue Vaccine In Final Stage Of Clinical Development

Health : Medical News Today

Sanofi Pasteur, the vaccines division of sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that its dengue vaccine is in final stage of clinical development. Sanofi Pasteur's dengue vaccine, the world's most clinically a...

Comments


Copyright © 2016 Regator, LLC